New drugs, strong marketing help Square Pharma maintain growth trend | The Business Standard
Skip to main content
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Friday
May 09, 2025

Sign In
Subscribe
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
FRIDAY, MAY 09, 2025
New drugs, strong marketing help Square Pharma maintain growth trend

Stocks

TBS Report
20 October, 2022, 09:25 pm
Last modified: 20 October, 2022, 11:22 pm

Related News

  • Square Pharma posts double-digit growth, earns Tk5,785cr in 9 months
  • Square Pharma vice chairman to purchase shares worth Tk33cr
  • Square Pharma director to buy company shares worth Tk32cr
  • Seminar on biomechanics of mental health held at UIU
  • When the product becomes the 'promotion'

New drugs, strong marketing help Square Pharma maintain growth trend

TBS Report
20 October, 2022, 09:25 pm
Last modified: 20 October, 2022, 11:22 pm
Infographic: TBS
Infographic: TBS

Square Pharmaceuticals Ltd — one of the large-cap companies listed in the capital market — has once again posted growth in its business, thanks to its launching of new drugs as well as strengthening its marketing strategy.  

The company's consolidated revenue grew 13.82% to Tk6,640 crore, and profit 14% to Tk1,818 crore in fiscal 2021-22, compared to the previous fiscal year.

Its earnings per share (EPS) stood at Tk20.51 in FY22.

Not only did the company's consolidated figures increase, but its subsidiaries also posted growths individually.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

Square Pharma's Chief Financial Officer (CFO) Md Zahangir Alam said the company had strongly focused on its marketing for growth during the year despite the market being slow in the last two quarters.

Also, it was trying to launch new drugs in the market that played an important role in the company's business, he added.

The company recommended a 100% cash dividend for its shareholders for FY22.

To secure approval of the dividend from its shareholders, the company has fixed 24 December for its online annual general meeting. The record date is 28 November.

Its board of directors also approved a Tk300 crore Balancing, Modernisation, Rehabilitation, and Expansion (BMRE) investment plan for buying new capital machinery and land for future expansion.

According to the Bangladesh Association of Pharmaceutical Industries, the country's pharmaceuticals industry is growing by 15% every year, and is expected to grow four times to Tk1 trillion by 2030. Square Pharma is the industry leader and holds around 17% of the market share.

The company was launched in 1958 and has been publicly listed since 1995.

The last trading share price of the company on the Dhaka Stock Exchange was Tk209.8 per share on Thursday.

Top News

Square Pharma / Square Pharmaceuticals Ltd / Marketing

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • The protesters gather in front of Chief Adviser's Jamuna residence in the capital tonight (8 May), demanding a ban on Awami League. Photo: TBS
    'Won't move without clear roadmap on AL ban': Protesters, led by NCP, stage sit-in in front of CA's residence
  • Screengrab from video shared by Adviser Asif Mahmud
    Jubo League, Swechchhasebak League to be banned; process in final stage: Adviser Asif Mahmud
  • Bangladesh Bank. File Photo: Collected
    Bangladesh Bank tightens credit facility for bank directors and affiliates

MOST VIEWED

  • Bangladesh Investment Development Authority (Bida) Chairman Ashik Chowdhury speaks to media in Chattogram on 8 May 2025. Photo: TBS
    Free Trade Zone to be established on 400 acres in Ctg, AP Moller-Maersk to invest $800m: Bida Chairman
  • Why Atomic Energy Commission resists joining govt's digital payment system
    Why Atomic Energy Commission resists joining govt's digital payment system
  •  Fragments of what Pakistan says is a drone. May 8, 2025. Photo: Reuters
    Pakistan denies involvement in drone attack in Indian Kashmir, calls it ‘fake’
  • Representational image
    From next FY, parliament takes control of tax exemptions, capped at 5 years
  • A pink bus stops mid-road in Dhaka’s Shyamoli on Monday, highlighting the challenges facing a reform effort to streamline public transport. Despite involving 2,600 buses and rules against random stops, poor enforcement, inadequate ticket counters, and minimal change have left commuters disillusioned and traffic chaos largely unchanged. Photo:  Syed Zakir Hossain
    Nagar Paribahan, pink bus services hit snag in Dhaka's transport overhaul
  • Metal debris lies on the ground in Wuyan in south Kashmir's Pulwama district district May 7, 2025. Photo: REUTERS/Sharafat Ali
    Pakistan warns of nuclear war as India-Pakistan conflict escalates

Related News

  • Square Pharma posts double-digit growth, earns Tk5,785cr in 9 months
  • Square Pharma vice chairman to purchase shares worth Tk33cr
  • Square Pharma director to buy company shares worth Tk32cr
  • Seminar on biomechanics of mental health held at UIU
  • When the product becomes the 'promotion'

Features

Graphics: TBS

Why can’t India and Pakistan make peace?

11h | The Big Picture
Graphics: TBS

What will be the fallout of an India-Pakistan nuclear war?

11h | The Big Picture
There were a lot more special cars in the halls such as the McLaren Artura, Lexus LC500, 68’ Mustang and the MK4 Supra which, even the petrolheads don't get to spot often. PHOTO: Arfin Kazi

From GTRs to V12 royalty: Looking back at Curated Cars by Rahimoto and C&C

1d | Wheels
The lion’s share of the health budget still goes toward non-development or operational expenditures, leaving little for infrastructure or innovation. Photo: TBS

Healthcare reform proposals sound promising. But what about financing?

2d | Panorama

More Videos from TBS

Why is China confident that the U.S. will lose the trade war?

Why is China confident that the U.S. will lose the trade war?

6h | Others
NCP strongly criticizes government over Abdul Hamid's departure from the country

NCP strongly criticizes government over Abdul Hamid's departure from the country

6h | TBS Today
Pakistan missile attack in Jammu

Pakistan missile attack in Jammu

7h | TBS News Updates
Relations with businessmen, Trump and Modi on the same path

Relations with businessmen, Trump and Modi on the same path

8h | TBS World
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net